Efficacy and safety profile of autologous blood talc pleurodesis for malignant pleural effusion: a randomized controlled trial
Background: Autologous blood is a novel, high-efficacy sclerosant for treatment of malignant pleural effusion (MPE), similar to tetracycline. There has been no comparative data between autologous blood and a worldwide sclerosant like talc. We aimed to compare the effectiveness of autologous blood ve...
Main Authors: | Warangkana Keeratichananont, Apichat Kaewdech, Suriya Keeratichananont |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-12-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753466618816625 |
Similar Items
-
Efficacy and safety profile of autologous blood tetracycline pleurodesis for malignant pleural effusion
by: Warangkana Keeratichananont, et al.
Published: (2015-04-01) -
Efficacy and safety of autologous blood pleurodesis versus talc pleurodesis in symptomatic pleural effusions: A randomized trial
by: Muzaffer Metintas, et al.
Published: (2021-01-01) -
Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis.
by: Huan Xia, et al.
Published: (2014-01-01) -
Management of Malignant Pleural Effusions with Indwelling Pleural Catheters or Talc Pleurodesis
by: Nadim Srour, et al.
Published: (2013-01-01) -
Predictors of talc slurry pleurodesis success in patients with malignant pleural effusions
by: P.S. Santos, et al.
Published: (2017-07-01)